S1. Drug design and screening

Session 1: Drug design and screening

Drug design and screening for anti malarials
Session Chair: Barry Hardy, Douglas Connect / Scientists Against Malaria

Monday, 9 February 2015
from 09:00 to 12:00

Speakers Title
Jurgen Bosch, Johns Hopkins Protein-protein Interaction Inhibitors in Antimalarial Drug Design
Barry Hardy, Scientists Against Malaria Malarial Kinase Inhibitor Design and Screening
Paul Hawkins, OpenEye Scientific Software Ligand-based virtual screening in 3D: where is the signal?
Raymond Hui, Structural Genomics Consortium Structural Biology of Malarial Kinases
Session 1 Summary

This session will discuss the application of computational chemistry, drug design, virtual and experimental screening techniques to the design of inhibitors against malarial targets.

   SESSION 2 >>